1,4-anthraquinone has been researched along with Leishmaniasis, Visceral in 1 studies
*Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaña-Fouce, R; Castro, MÁ; Escudero-Martínez, JM; García, PA; Jambrina, PG; Pérez-Pertejo, Y; Reguera, RM; San Feliciano, A | 1 |
1 other study(ies) available for 1,4-anthraquinone and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB.
Topics: Animals; Anthraquinones; Antiprotozoal Agents; Camptothecin; DNA Topoisomerases; Drug Resistance; Female; Hep G2 Cells; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Naphthoquinones; Quinones; Spleen; Topoisomerase Inhibitors | 2019 |